Located at the Smilow Center for Translational Research Auditorium/Commons at Penn Medicine (enter through Perelman Center for Advanced Medicine).
7:30-8:15 AM
Registration
8:15-8:30 AM
Welcome
MORNING SESSION
8:30-9:00 AM
Daniel Lin, MD
The Utility of Enhanced Screening for People with Inherited Risk of Developing Aggressive Prostate Cancer: Initial Results from the PATROL Study
9:00-9:30 AM
Tobias Else, MD
POT1 Tumor Predisposition Syndrome: Emerging Insights and Evolving Clinical Practice
9:30-10:00 AM
Anna Raper, MS, CGC
Germline POT1
10:00-10:30 AM
BREAK
10:30-11:00 AM
Jessica Long, MS, CGC, CGAF
Year in Review
11:00-12:00 PM
Case Panel moderated by Susan Domchek, MD with:
Mark Robson, MD
12:00-12:45 PM
LUNCH
AFTERNOON SESSION
12:45-1:15 PM
Susan Domchek, MD
Genetics Testing for Cancer Susceptibility in 2026: Which Genes, Which Patients and How
1:15-1:45 PM
Heather Hampel, MS, CGC
Managing Results from a Point-of-Care Germline Genetic Testing Program: The Good, the Bad, and the Ugly
1:45-2:15 PM
Catharine Wang, PhD, MSc
Patient Engagement and BRCA Testing: Unpacking Contextual Factors Driving Test Uptake
2:15-2:45 PM
Theodore Drivas, MD, PhD
Overlooked and Underdiagnosed: Addressing the Genetic Testing Void in Adult Patients
End of accredited portion
2:45-3:15 PM
BREAK
3:15-4:30 PM
Ephrat Levy-Lahad, MD
Global Prize Presentation and Keynote
Population Screening for BRCA: From One to Many
4:45-5:30 PM
Poster Session